Patents by Inventor Emma von Witting

Emma von Witting has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BISPECIFIC PROTEIN
    Publication number: 20230250160
    Abstract: The present disclosure provides for a bispecific protein that enables simultaneous binding of both albumin and a desired target to an ADAPT (ABD Derived Affinity ProTeins) molecule. The present disclosure provides for an ADAPT molecule wherein the proposed binding surface of the desired target is located on helix 1 and helix 2 of the ADAPT molecule.
    Type: Application
    Filed: April 29, 2021
    Publication date: August 10, 2023
    Inventors: Sophia Hober, Sarah Lindbo, Emma von Witting
  • THERAPEUTIC AGENT TARGETING HER2
    Publication number: 20230107890
    Abstract: There is provided a therapeutic conjugate comprising a fusion protein and a cytotoxic radionuclide, which cytotoxic radionuclide is bound to the fusion protein. The fusion protein comprises a certain HER2-binding region (HBR), a certain albumin-binding region (ABR) and a spacer region.
    Type: Application
    Filed: March 9, 2021
    Publication date: April 6, 2023
    Inventors: Sophia Hober, Emma von Witting, Javad Garousi, Vladimir Tolmachev